Global Contract Manufacturing in the In-vitro Diagnostics (IVD) Market 2023

April 2023 | 48 pages | ID: G4A656C4101AEN
Gen Consulting Company

Abstracts

Contract manufacturing in the in-vitro diagnostics (IVD) allows IVD companies to focus on their core competencies, such as research and development, marketing, and sales, while leaving the manufacturing process to a specialized contract manufacturer. The contract manufacturing of IVD tests includes various stages, such as design, development, and production. Contract manufacturers work closely with IVD companies to ensure that the design and development of the test meet the required specifications. They also ensure that the test is produced in compliance with regulatory requirements. The global contract manufacturing in the in-vitro diagnostics (ivd) market is anticipated to increase by USD 5.7 billion till 2029 at an average annual growth of 8.4 percent as per the latest market estimates.

This industry report offers market estimates of the global market, followed by a detailed analysis of the practice area, and region. The global market data on contract manufacturing in the in-vitro diagnostics (ivd) can be segmented by practice area: assays and consumables, clinical development, full product development, research and development, testing and evaluation services. The research and development segment held the largest share of the global contract manufacturing in the in-vitro diagnostics (ivd) market in 2022 and is anticipated to hold its share during the forecast period. Contract manufacturing in the in-vitro diagnostics (ivd) market is further segmented by region: North America, Europe, Asia-Pacific, Rest of World (RoW). Globally, North America made up the largest share of the contract manufacturing in the in-vitro diagnostics (ivd) market.

The global contract manufacturing in the in-vitro diagnostics (ivd) market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Agilent Technologies Inc., Biokit S.A., Denka Seiken Co. Ltd., Flex Ltd., FUJIFILM Wako Pure Chemical Corporation, Fujirebio Inc, Merck Millipore Ltd, Meridian Life Science Inc, Plexus Corporation, Sekisui Diagnostics LLC, Tecan Group Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Contract Manufacturing in the In-vitro Diagnostics (IVD) Market
• Identify segments/areas to invest in over the forecast period in the Global Contract Manufacturing in the In-vitro Diagnostics (IVD) Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. CONTRACT MANUFACTURING IN THE IN-VITRO DIAGNOSTICS (IVD) MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRACTICE AREA

Assays and consumables
Clinical development
Full product development
Research and development
Testing and evaluation services

PART 5. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
Rest of World (RoW)

PART 6. KEY COMPANIES

Agilent Technologies, Inc.
Biokit S.A.
Denka Seiken Co., Ltd.
Flex Ltd.
FUJIFILM Wako Pure Chemical Corporation
Fujirebio, Inc
Merck Millipore Ltd
Meridian Life Science Inc
Plexus Corporation
Sekisui Diagnostics LLC
Tecan Group Ltd.

PART 7. METHODOLOGY